HTS automation integrates robotics, liquid handling, detection systems and software to streamline drug discovery workflows.

This article is based on a poster originally authored by Ariane Jonetz-Mentzel et al. In biopharmaceutical laboratories, there is an increasing demand for label-free, high-throughput screening based ...

QIAsprint Connect marks entry into high-throughput sample processing, enabling labs to scale workflows with flexible protocols, compact design and sustainability-focused features QIAGEN also to ...

Revvity offers comprehensive solutions designed to help accelerate laboratory workflows, assisting researchers meet targets faster and bring new therapies to market sooner. Our integrated approach ...

Molecular Devices developed an end-to-end, automated workflow, beginning with assay-ready colorectal cancer organoids, comprising establishment in culture, maintenance, and screening. Automation ...

The global High Throughput Screening Market was valued at USD 13370 Million in the year 2024 and is projected to reach a revised size of USD 17880 Million by 2031, growing at a CAGR of 4.3% during the ...

To enhance productivity in research laboratories conducting genomic studies, automation techniques along with rapid workflows are encouraged. Here, we discuss gene expression analysis by ...

Genome and epigenome editors—including CRISPR nucleases, base editors, prime editors, and emerging RNA/epitranscriptomic editors—are advancing rapidly, but ...

CHICAGO--(BUSINESS WIRE)--SAMDI Tech, Inc., the industry’s leading provider of label-free drug discovery solutions, today announced that Chief Scientific Officer Zachary Gurard-Levin, Ph.D., has been ...